740
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Streptococcus suis serotype 4: a population with the potential pathogenicity in humans and pigs

, , , , ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Article: 2352435 | Received 10 Jan 2024, Accepted 02 May 2024, Published online: 15 May 2024
 

ABSTRACT

Streptococcus suis is a major bacterial pathogen in pigs and an emerging zoonotic pathogen. Different S. suis serotypes exhibit diverse characteristics in population structure and pathogenicity. Surveillance data highlight the significance of S. suis serotype 4 (SS4) in swine streptococcusis, a pathotype causing human infections. However, except for a few epidemiologic studies, the information on SS4 remains limited. In this study, we investigated the population structure, pathogenicity, and antimicrobial characteristics of SS4 based on 126 isolates, including one from a patient with septicemia. We discovered significant diversities within this population, clustering into six minimum core genome (MCG) groups (1, 2, 3, 4, 7-2, and 7-3) and five lineages. Two main clonal complexes (CCs), CC17 and CC94, belong to MCG groups 1 and 3, respectively. Numerous important putative virulence-associated genes are present in these two MCG groups, and 35.00% (7/20) of pig isolates from CC17, CC94, and CC839 (also belonging to MCG group 3) were highly virulent (mortality rate ≥ 80%) in zebrafish and mice, similar to the human isolate ID36054. Cytotoxicity assays showed that the human and pig isolates of SS4 strains exhibit significant cytotoxicity to human cells. Antimicrobial susceptibility testing showed that 95.83% of strains isolated from our labs were classified as multidrug-resistant. Prophages were identified as the primary vehicle for antibiotic resistance genes. Our study demonstrates the public health threat posed by SS4, expanding the understanding of SS4 population structure and pathogenicity characteristics and providing valuable information for its surveillance and prevention.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Ethical approval

Animal infection experiments were conducted at the Laboratory Animal Center of Nanjing Agricultural University (Permit number: SYXK (Su) 2021-0086). This study and the application of the animal experiments were reviewed and approved by the Experimental Animal Welfare and Ethics Committee of Nanjing Agricultural University and were performed according to Animal Welfare Agency Guidelines.

Additional information

Funding

This work was supported by grants from the National Key Research and Development Program of China [2021YFD1800402], the National Natural Science Foundation of China [32172859], Open Project Program of Jiangsu Key Laboratory of Zoonosis [R2103], and Open Project Program of Engineering Research Center for the Prevention and Control of Animal Original Zoonosis, Fujian Province University [2021ZW001].